Results 331 to 340 of about 1,213,487 (359)

Reassessment of Progression-Free Survival as a Surrogate End Point of Overall Survival

2023
Progression-free survival (PFS) has been increasingly used as a surrogate endpoint for overall survival (OS) by FDA in cancer drug approval. However, whether PFS can fully represent OS has remained uncertain. Breast cancer is the most prevalent cancer among females, and PFS has been the most common endpoint in drug approval trials for decades ...
openaire   +1 more source

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Ahmedin Jemal Dvm   +2 more
exaly  

Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

Ca-A Cancer Journal for Clinicians, 2023
Elliot A Asare
exaly  

Cancer treatment and survivorship statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Kimberly D Miller, Leticia M Nogueira, Angela B Mariotto   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival

Ca-A Cancer Journal for Clinicians, 2022
exaly  

Progression-free survival as endpoint in metastatic RCC?

The Lancet, 2008
openaire   +3 more sources

A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change

Ca-A Cancer Journal for Clinicians, 2015
Bobby Daly, Olufunmilayo I Olopade
exaly  

Young Adult Oncology: The Patients and Their Survival Challenges

Ca-A Cancer Journal for Clinicians, 2007
W Archie Bleyer
exaly  

Cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2013
Ahmedin Jemal
exaly